Event Registration for Industry Professionals | Consensus or Controversy? Immune Checkpoint Inhibition in the Management of Metastatic Lung Cancer — November 8, 2018, Washington, DC
Submissions for this form are closed.
This program is intended for medical oncologists, hematology-oncology fellows and other allied healthcare professionals involved in the treatment of lung cancer.